Skip to main content

Table 2 Summary of treatment

From: Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinoma

Patient no.

TKIs + ICIs

TACE/RFA

1–21

Len + Sin

~

22–31

Len + Sin

TACE

32

Len + Sin

TACE + RFA

33–34

Len + Pem

~

35–36

Len + Pem

TACE

37

Len + Niv

~

38–39

Len + Niv

TACE

40–41

Len + Niv

TACE + RFA

42

Apa + Pem

~

43

Apa + Sin

~

44

Apa + Sin

TACE

  1. TKIs tyrosine kinase inhibitors, Len lenvatinib, Apa apatinib, Sin sintilimab, Pem pembrolizumab, Niv nivolumab, TACE trans-arterial chemoembolization, RFA radiofrequency ablation, ~ none
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us